Cipla | CIPLA - Операционные расходы





Операционные расходы Изменить Дата
Arca Biopharma USD 34.43M 326K 2025-12
aTyr Pharma USD 85.61M 58.67M 2025-12
Bio Path USD 488K 4.07M 2025-09
Brainstorm Cell Therapeutics USD 2.24M 197K 2025-12
Capricor Therapeutics USD 29.16M 2.87M 2025-12
Cara Therapeutics USD 5.94M 983K 2025-09
Cipla INR 59.27B 1.71B 2026-03
Dr.Reddys Laboratories INR 74.58B 977M 2026-03
Esperion Therapeutics USD 83.21M 14.06M 2025-12
Immunic USD 23.33M 2.67M 2025-12
Minerva Neurosciences USD 4.52M 155.46K 2024-12
Nektar Therapeutics USD 40.9M 44.19M 2025-12
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sun Pharmaceuticals INR 114.07B 2.96B 2025-12
TherapeuticsMD USD 1.41M 50K 2024-06
UPL INR 156.03B 49.4B 2026-03